Patent classifications
A01N37/06
Method of packaging food
The invention proposes a container further extending the shelf life of foods, particularly berries, by including an active agent having antifungal capability into the container surface so that when the fruit is packaged inside the container it is permanently exerted an antifungal effect over the surface, which is the place on the longer determinants occurs, but also contributing to preserve the general environment. Also it proposes a preparation process and its use.
Insect repelling composition
A composition and method for insect repellent is provided. The composition in one form has on a weight percentage basis 2-4% α-pinene; 2-4% borneol; 8-10% geraniol; 28-35% linalool; 25-38% linalyl acetate; 1-4% methyl salicylate; 2-4% myrcene; 2-4% para-cymene; 4-8% phellendrene; 1-4% thymol; and 2-4% vanillin. The composition has insect repellent properties.
Insect repelling composition
A composition and method for insect repellent is provided. The composition in one form has on a weight percentage basis 2-4% α-pinene; 2-4% borneol; 8-10% geraniol; 28-35% linalool; 25-38% linalyl acetate; 1-4% methyl salicylate; 2-4% myrcene; 2-4% para-cymene; 4-8% phellendrene; 1-4% thymol; and 2-4% vanillin. The composition has insect repellent properties.
VOLATILE COMPOSITION
Provided is a volatile composition having a small difference in volatilization amounts of a volatile substance within a wide temperature range from the normal temperature and enabling the control of the volatilization amount even at a high temperature by suppressing the volatilization amount of the volatile substance and by increasing the gel strength of the volatile composition. Specifically provided is a volatile composition having an alkyl cellulose having such a viscosity that a viscosity at 20° C. of a 1% by weight aqueous solution of the alkyl cellulose is 4,000 to 11,000 mPa.Math.s as determined by a Brookfield viscometer and having such a storage elastic modulus that a storage elastic modulus G′(65° C.) at 65° C. of a 1.5% by weight aqueous solution of the alkyl cellulose is 3,000 to 4,500 Pa; a volatile substance; and a solvent.
VOLATILE COMPOSITION
Provided is a volatile composition having a small difference in volatilization amounts of a volatile substance within a wide temperature range from the normal temperature and enabling the control of the volatilization amount even at a high temperature by suppressing the volatilization amount of the volatile substance and by increasing the gel strength of the volatile composition. Specifically provided is a volatile composition having an alkyl cellulose having such a viscosity that a viscosity at 20° C. of a 1% by weight aqueous solution of the alkyl cellulose is 4,000 to 11,000 mPa.Math.s as determined by a Brookfield viscometer and having such a storage elastic modulus that a storage elastic modulus G′(65° C.) at 65° C. of a 1.5% by weight aqueous solution of the alkyl cellulose is 3,000 to 4,500 Pa; a volatile substance; and a solvent.
THERAPEUTIC COMPOSITIONS OF DECANOIC ACID AND ARGININE
Compositions including a complex of fatty acids (e.g., including one or more C4 to C40 fatty acids, such as a C4 to C20 fatty acid) and one or more amino acids (and particularly one or more amino acids having electrically charged basic side chains, e.g., Arginine, Lysine, etc.) for use as an anti-pathogenic composition. In particular, described herein are compositions of decanoic acid: Arginine in which the decanoic acid and Arginine for a complex having a lamellar supramolecular structure.
THERAPEUTIC COMPOSITIONS OF DECANOIC ACID AND ARGININE
Compositions including a complex of fatty acids (e.g., including one or more C4 to C40 fatty acids, such as a C4 to C20 fatty acid) and one or more amino acids (and particularly one or more amino acids having electrically charged basic side chains, e.g., Arginine, Lysine, etc.) for use as an anti-pathogenic composition. In particular, described herein are compositions of decanoic acid: Arginine in which the decanoic acid and Arginine for a complex having a lamellar supramolecular structure.
Sustained Release Pheromone Preparation of Vine Mealybug and Control Method Using the Preparation
Provided are a sustained release pheromone preparation capable of maintaining a high amount of pheromone release throughout a control period of vine mealybug (VMB) having lavandulyl senecioate (LVSN) as a pheromone substance; and a control method with the preparation. More specifically, provided are a sustained release pheromone preparation comprising a first pheromone substance, and a first container having the first pheromone substance sealed therein and comprising a first polymer membrane made of an ethylene vinyl acetate copolymer containing vinyl acetate units of from 0.5 to 10% by weight, wherein the first pheromone substance is lavandulyl senecioate, which is a pheromone substance of vine mealybug, and the lavandulyl senecioate can be released into the air through the first polymer membrane for 150 days or more; and others.
Sustained Release Pheromone Preparation of Vine Mealybug and Control Method Using the Preparation
Provided are a sustained release pheromone preparation capable of maintaining a high amount of pheromone release throughout a control period of vine mealybug (VMB) having lavandulyl senecioate (LVSN) as a pheromone substance; and a control method with the preparation. More specifically, provided are a sustained release pheromone preparation comprising a first pheromone substance, and a first container having the first pheromone substance sealed therein and comprising a first polymer membrane made of an ethylene vinyl acetate copolymer containing vinyl acetate units of from 0.5 to 10% by weight, wherein the first pheromone substance is lavandulyl senecioate, which is a pheromone substance of vine mealybug, and the lavandulyl senecioate can be released into the air through the first polymer membrane for 150 days or more; and others.
BIOMIMETIC POLYMERS FOR THE PREVENTION AND TREATMENT OF VIRAL DISEASES
Antiviral biomimetic polymers (ABPs) are disclosed that can be used to prevent and/or treat viral disease. The ABPs are discovered by a process involving high-throughput screening of polymer libraries using disease-relevant bioactive molecules as target molecules. ABPs can be nanoscale (termed nanoABPs) or larger. Methods are described for the preparation and use of ABPs as prophylactics and therapeutics (in vivo) and as preventative agents, for example, in personal protective equipment (ex vivo). ABPs can be used to prevent and treat viral diseases including those caused by Filoviridae.